Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy | Zendy

Rainer Görges | Zendy; Maciej Bogdan Maniecki | Zendy; Walter Jentzen | Zendy; Sie n-Yi Sheu | Zendy; Klaus Mann | Zendy; A. Bockisch | Zendy; Onno E. Janßen | Zendy

Open Access

Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy

Author(s) -

Rainer Görges,

Maciej Bogdan Maniecki,

Walter Jentzen,

Sie n-Yi Sheu,

Klaus Mann,

A. Bockisch,

Onno E. Janßen

Publication year - 2005

Publication title -

european journal of endocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.897

H-Index - 148

eISSN - 1479-683X

pISSN - 0804-4643

DOI - 10.1530/eje.1.01940

Subject(s) - medicine , thyroglobulin , thyroid carcinoma , autoantibody , endocrinology , thyroid , thyroid cancer , thyroidectomy , gastroenterology , antibody , immunology

Cross-sectional studies have reported an increased prevalence of circulating thyroglobulin autoantibodies (TgAbs) in patients with differentiated thyroid carcinoma (DTC). With the advent of more sensitive assays, a longitudinal study monitoring the development of TgAb levels after ablative therapy was warranted.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research